Schuchardt, Florian http://orcid.org/0000-0002-2549-3089
Demerath, T. http://orcid.org/0000-0002-5869-1110
Lützen, N. http://orcid.org/0000-0003-0555-7863
Elsheikh, S. http://orcid.org/0000-0002-3796-5709
Lagrèze, W. http://orcid.org/0000-0002-3558-5905
Reich, M. http://orcid.org/0000-0002-9813-8483
Küchlin, S. http://orcid.org/0000-0003-0758-5120
Urbach, H. http://orcid.org/0000-0001-7264-4807
Meckel, S. http://orcid.org/0000-0001-6468-4526
Harloff, A. http://orcid.org/0000-0002-3252-7910
Article History
Received: 25 July 2022
Accepted: 15 November 2022
First Online: 29 November 2022
Declarations
:
: None of the authors declares conflicts of interest directly related to the study.FS: unrelated to the submitted study: previous work on dural arterio-venous fistula in cerebral venous thrombosis was partially supported by Forschungskommission, Medical Faculty, Albert-Ludwigs-University, Freiburg (SCHU 1097/16). Grant 01VSF19053 by the Innovation Committee of the Federal Joint Committee (gemeinsamer Bundesausschuss).TD: none declared.NL: none declared.SE: unrelated to the submitted study: research grant from Bracco S.p.A.; Forschungskommission, Medical Faculty, Albert-Ludwigs-University, Freiburg; Local PI of the Inspire Register-S, Medtronic.WL: none declared.MR: honorary as speaker in “OphthalmoLive – Schielen 2021”, unrelated to the study.SK: none declared.HU: honoraria for lectures from Eisai, Biogen, Mbits, Advisory Board Biogen, Shareholder Veobrain GmbH (up to 2019).SM: Unrelated to present study: research grants (money paid to institution) from Bracco S.p.A., Novartis Pharma GmbH and Federal Ministry of Education and Research (BMBF) / Germany: research grant 2019-2021 (FKZ 13GW0359C); consulting fees from Acandis GmbH: consultant (ongoing-1/2023), Microvention: consultant (2/2021-1/2023), Stryker: consultant (2/2021-1/2023), Novartis Pharma GmbH: consultant; speaker honorarium from Medtronic: (modest) ÖGNR Klagenfurt 11/2021; travel support from Microvention, Stryker, Medtronic.AH: Grant HA 5399/5-1 by the German Research Society (DFG), funding by the Berta-Ottenstein-Programme for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg, Germany, not related to the submitted article. Honoraria for lectures by AMGEN and Bristol-Myers-Squibb.
: The reporting of results adheres to the STARD recommendations.
: The study was approved by the ethics committee of our institution (protocol number 306/10) and conformed to the Declaration of Helsinki.
: All study participants gave their written informed consent.